The company's SteadiSet infusion set for insulin pump therapy features a kink-proof, flexible, multiport cannula with a simple one-handed insertion and a user-friendly design, which improves the reliability and comfort of insulin delivery. Capillary Biomedical aims to reduce the burden of diabetes on patients and the healthcare system by achieving more consistent and reliable insulin absorption, enabling people with diabetes to achieve improved blood glucose control. The company is based in Irvine, CA, and is a spin-out of the Artificial Pancreas Center at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia, PA, where the academic-industry collaboration focuses on improving the comfort, reliability, and predictability of insulin infusion therapy.